Odonate Therapeutics, Inc.

ODTC · OTC
Analyze with AI
12/31/2022
9/30/2022
12/31/2021
9/30/2021
Operating Activities
Net Income$5$1-$14
Dep. & Amort.$0$0$0
Deferred Tax$1$0$0
Stock-Based Comp.$0$0$1
Change in WC-$0-$16-$2
Other Non-Cash$0$2$0
Operating Cash Flow$5-$13-$15
Investing Activities
PP&E Inv.$0$0$0
Net Acquisitions$0$0$0
Inv. Purchases-$37$0$0
Inv. Sales/Matur.$0$0$0
Other Inv. Act.$0$0$0
Investing Cash Flow-$37$0$0
Financing Activities
Debt Repay.$0$0$0
Stock Issued$0$0$0
Stock Repurch.$0-$14$0
Dividends Paid$0$0$0
Other Fin. Act.$0-$14$0
Financing Cash Flow$0-$14$0
Forex Effect$0$0$0
Net Chg. in Cash-$32-$26-$15
Supplemental Information
Beg. Cash$43$95$111
End Cash$11$69$96
Free Cash Flow$5-$13-$15